The bioavailability, absorption characteristics and formulation of four commercially-available controlled-release theophylline products
- 30 April 1986
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 30 (1) , 83-88
- https://doi.org/10.1016/0378-5173(86)90138-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- An in Vivo Single- and Multiple-Dose Study of Several Marketed Brands of Conventional and Controlled-Release TheophyllineDrug Intelligence & Clinical Pharmacy, 1984
- Absorption Kinetics and Steady-State Plasma Concentrations of Theophylline Following Therapeutic Doses of Two Sustained-Release PreparationsJournal of Pharmaceutical Sciences, 1983
- Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tabletEuropean Journal of Clinical Pharmacology, 1983
- The Relation of Product Formulation to Absorption of Oral TheophyllineNew England Journal of Medicine, 1978
- Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicityJAMA, 1976
- Dosage of Theophylline in Bronchial AsthmaNew England Journal of Medicine, 1975
- Influence of diet and fluid on bioavailability of theophyllineClinical Pharmacology & Therapeutics, 1975
- Rational Intravenous Doses of TheophyllineNew England Journal of Medicine, 1973
- Pharmacokinetics of theophylline; Application to adjustment of the clinical dose of aminophyllineClinical Pharmacology & Therapeutics, 1972